OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon

OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon

Source: 
CP Wire
snippet: 
  • Current dry-powder glucagon formulations must be used immediately because they begin to degrade after reconstitution
  • Xeris’ ready-to-use liquid glucagon is room-temperature stable over extended periods of time
  • The ability to deliver both insulin and glucagon may reduce the risk of hypoglycemia by mirroring the body’s normal glucose control,